These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. The Natural Agonist of Estrogen Receptor β Silibinin Plays an Immunosuppressive Role Representing a Potential Therapeutic Tool in Rheumatoid Arthritis. Dupuis ML; Conti F; Maselli A; Pagano MT; Ruggieri A; Anticoli S; Fragale A; Gabriele L; Gagliardi MC; Sanchez M; Ceccarelli F; Alessandri C; Valesini G; Ortona E; Pierdominici M Front Immunol; 2018; 9():1903. PubMed ID: 30174672 [TBL] [Abstract][Full Text] [Related]
8. Cytokine mRNA in the joints and draining lymph nodes of rats with adjuvant arthritis and effects of cyclosporin A. Ayer LM; Issekutz AC; Waterhouse CC; Stadnyk AW Inflammation; 2000 Oct; 24(5):447-61. PubMed ID: 10921508 [TBL] [Abstract][Full Text] [Related]
9. Mechanisms of corticosteroid resistance in rheumatoid arthritis: a putative role for the corticosteroid receptor beta isoform. Chikanza IC Ann N Y Acad Sci; 2002 Jun; 966():39-48. PubMed ID: 12114257 [TBL] [Abstract][Full Text] [Related]
10. New therapeutics in rheumatoid arthritis. Savage C; St Clair EW Rheum Dis Clin North Am; 2006 Feb; 32(1):57-74, viii. PubMed ID: 16504821 [TBL] [Abstract][Full Text] [Related]
11. IL-17 in rheumatoid arthritis: a new target for treatment or just another cytokine? Miossec P Joint Bone Spine; 2004 Mar; 71(2):87-90. PubMed ID: 15050191 [No Abstract] [Full Text] [Related]
12. Selected cytokine pathways in rheumatoid arthritis. Noack M; Miossec P Semin Immunopathol; 2017 Jun; 39(4):365-383. PubMed ID: 28213794 [TBL] [Abstract][Full Text] [Related]
13. Molecular targets in immune-mediated diseases: focus on rheumatoid arthritis. Cook AD; Visvanathan K Expert Opin Ther Targets; 2004 Oct; 8(5):375-90. PubMed ID: 15469389 [TBL] [Abstract][Full Text] [Related]
14. Cytokine expression and networks in rheumatoid arthritis: rationale for anti-TNF alpha antibody therapy and its mechanism of action. Feldmann M; Brennan FM; Williams RO; Elliott MJ; Maini RN J Inflamm; 1995-1996; 47(1-2):90-6. PubMed ID: 8913935 [TBL] [Abstract][Full Text] [Related]
15. Cytokine pathways and joint inflammation in rheumatoid arthritis. Choy EH; Panayi GS N Engl J Med; 2001 Mar; 344(12):907-16. PubMed ID: 11259725 [No Abstract] [Full Text] [Related]
18. [Development of new drugs for the treatment of rheumatoid arthritis]. Mizushima Y Nihon Rinsho; 1992 Mar; 50(3):526-30. PubMed ID: 1588742 [TBL] [Abstract][Full Text] [Related]